Vestal Point Capital »

Sagimet Biosciences Inc-a shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Sagimet Biosciences Inc-a (SGMT) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Sagimet Biosciences Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Sagimet Biosciences Inc-a held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sagimet Biosciences Inc-a by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.1M 536k 7.73

More positions owned by Vestal Point Capital

BioMarin Pharmaceutical (BMRN)
Neurocrine Biosciences (NBIX)
Abivax SA Sponsored Ads (ABVX)
United Therapeutics Corporation (UTHR)
Enliven Therapeutics (ELVN)
Nurix Therapeutics (NRIX)
Bicara Therapeutics (BCAX)
Taysha Gene Therapies Com Shs (TSHA)
Arrowhead Pharmaceuticals (ARWR)
Abbott Laboratories (ABT)
Zimmer Holdings (ZBH)
Disc Medicine (IRON)
Monte Rosa Therapeutics (GLUE)
Insulet Corporation (PODD)
Ascendis Pharma A/S Ord Shs (ASND)

View all positions for Vestal Point Capital

Top funds holding Sagimet Biosciences Inc-a

BlackRock
Balyasny Asset Management
Woodline Partners
Silverarc Capital Management
Vanguard Capital Management
BVF
Caligan Partners
Affinity Asset Advisors
Federated Investors
Dr. Jeffrey R. Jay, M.D.
Saturn V Capital Management
Geode Capital Management
Blue Owl Capital Holdings
Baker Bros. Advisors
Millennium Management

View all funds holding Sagimet Biosciences Inc-a